Comparison of Walking in Water and on Land in People With Chronic Obstructive Pulmonary Disease (COPD)
Primary Purpose
Pulmonary Disease, Chronic Obstructive
Status
Terminated
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Water-based walking
Land-based walking
Sponsored by
About this trial
This is an interventional treatment trial for Pulmonary Disease, Chronic Obstructive focused on measuring Hydrotherapy, Walking
Eligibility Criteria
Inclusion Criteria:
- diagnosis of COPD (FEV1/FVC <0.7) in a clinically stable state (no acute exacerbation of COPD within the previous 4 weeks)
- accepting of walking in water
- BMI >/= 21 kg/m2
Exclusion Criteria:
- long-term oxygen therapy
- contraindications to entering a hydrotherapy pool
Sites / Locations
- Centre of intergrated rehabilitation for chronic organ failure
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
COPD (normal weight)
COPD (obese)
Arm Description
People with COPD (BMI 21 kg/m2 to 29 kg/m2)
People with COPD (BMI >/= 30 kg/m2)
Outcomes
Primary Outcome Measures
Breath-by-breath oxygen consumption (VO2)
Secondary Outcome Measures
Minute ventilation (VE)
Full Information
NCT ID
NCT02757157
First Posted
April 7, 2016
Last Updated
August 19, 2021
Sponsor
European Respiratory Society
Collaborators
Center for Integrated Rehabilitation and Organ Failure Horn
1. Study Identification
Unique Protocol Identification Number
NCT02757157
Brief Title
Comparison of Walking in Water and on Land in People With Chronic Obstructive Pulmonary Disease (COPD)
Official Title
Determining the Metabolic Load of Walking in Water Compared to Walking on Land in People With COPD, Who Are Normal Weight and Obese, Compared to Peak Exercise Metabolic Response: a Prospective, Randomised Cross-over Pilot Trial
Study Type
Interventional
2. Study Status
Record Verification Date
August 2021
Overall Recruitment Status
Terminated
Why Stopped
Hydrotherapy pool has closed.
Study Start Date
October 2016 (undefined)
Primary Completion Date
January 1, 2020 (Actual)
Study Completion Date
January 1, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
European Respiratory Society
Collaborators
Center for Integrated Rehabilitation and Organ Failure Horn
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to evaluate the metabolic load during a single session of moderate intensity walking in water compared to walking on land (over-ground) in people with chronic obstructive pulmonary disease (COPD) who are normal weight and obese, compared with peak exercise metabolic response.
The hypothesis is that the metabolic load of walking at a moderate intensity in water will be greater than walking on land.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pulmonary Disease, Chronic Obstructive
Keywords
Hydrotherapy, Walking
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
14 (Actual)
8. Arms, Groups, and Interventions
Arm Title
COPD (normal weight)
Arm Type
Experimental
Arm Description
People with COPD (BMI 21 kg/m2 to 29 kg/m2)
Arm Title
COPD (obese)
Arm Type
Experimental
Arm Description
People with COPD (BMI >/= 30 kg/m2)
Intervention Type
Behavioral
Intervention Name(s)
Water-based walking
Intervention Description
Participants will walk in the water for 15 minutes at an intensity rating of five on the modified Borg scale for dyspnoea or perceived exertion, whichever is the highest. Walking intensity will be measured every three minutes during each walking session. If the intensity level is reported as below five, participants will be encouraged to increase the intensity by increasing their walking speed.
During walking in water, VO2 and VE will be measured breath-by-breath using the Oxycon mobile. Every three minutes during the walking, heart rate, oxygen saturation, dyspnoea and exertion will be measured.
Intervention Type
Behavioral
Intervention Name(s)
Land-based walking
Intervention Description
Participants will walk on land for 15 minutes at an intensity rating of five on the modified Borg scale for dyspnoea or perceived exertion, whichever is the highest. Walking intensity will be measured every three minutes during each walking session. If the intensity level is reported as below five, participants will be encouraged to increase the intensity by increasing their walking speed.
During walking on land, VO2 and VE will be measured breath-by-breath using the Oxycon mobile. Every three minutes during the walking, heart rate, oxygen saturation, dyspnoea and exertion will be measured.
Primary Outcome Measure Information:
Title
Breath-by-breath oxygen consumption (VO2)
Time Frame
Day of assessment during study measurement period (15 minutes)
Secondary Outcome Measure Information:
Title
Minute ventilation (VE)
Time Frame
Day of assessment during study measurement period (15 minutes)
Other Pre-specified Outcome Measures:
Title
Dyspnoea, measured by the modified Borg 0-10 category ratio scale
Time Frame
Day of assessment during study measurement period (15 minutes)
Title
Exertion, measured by the modified Borg 0-10 category ratio scale
Time Frame
Day of assessment during study measurement period (15 minutes)
Title
Oxygen saturation
Time Frame
Day of assessment during study measurement period (15 minutes)
Title
Heart rate
Time Frame
Day of assessment during study measurement period (15 minutes)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
diagnosis of COPD (FEV1/FVC <0.7) in a clinically stable state (no acute exacerbation of COPD within the previous 4 weeks)
accepting of walking in water
BMI >/= 21 kg/m2
Exclusion Criteria:
long-term oxygen therapy
contraindications to entering a hydrotherapy pool
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Martijn A Spruit, PhD
Organizational Affiliation
Centre of integrated rehabilitation for chronic organ failure
Official's Role
Study Director
Facility Information:
Facility Name
Centre of intergrated rehabilitation for chronic organ failure
City
Horn
Country
Netherlands
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Comparison of Walking in Water and on Land in People With Chronic Obstructive Pulmonary Disease (COPD)
We'll reach out to this number within 24 hrs